What Researchers Did
Researchers presented a case report of a 37-year-old woman who experienced ischemia after self-injecting a dermal filler and was successfully treated with hyperbaric oxygen therapy.
What They Found
A 37-year-old woman experienced immediate left-side hearing loss, facial blanching, and pain after self-injecting a dermal filler, with a computed tomography angiogram confirming superficial temporal artery branch occlusion. Following 6 hyperbaric oxygen therapy treatments over 3 days, her ischemic discoloration significantly decreased, and her hearing returned to baseline.
What This Means for Canadian Patients
Canadian patients considering cosmetic fillers should always seek treatment from qualified clinicians to avoid severe complications like ischemia. If complications arise, prompt medical attention, potentially including hyperbaric oxygen therapy, may help mitigate adverse outcomes such as hearing loss and tissue damage.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
This study is limited as a single case report, which restricts the generalizability of its findings.